Yesterday the TGA published the following update about this long-running saga:
Update following compliance with decision
“On 26 September 2013, Bayer Australia Limited advised the TGA that they have complied with and will continue to comply with the regulation 48 decision made by the delegate of the Minister for Health on 15 July 2013. This includes withdrawal of any representations, including implied representations, that “Berocca Performance” has been clinically trialled and demonstrated to improve concentration and reduce tiredness, and that they will not use these representations in any other advertisement”.
The history of this saga can be found here.
by 
